CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study
Se Hyun Kim, Kyung Hae Jung, Tae-Yong Kim, Seock-Ah Im, In Sil Choi, Yee Soo Chae, Sun Kyung Baek, Seok Yun Kang, Sarah Park, In Hae Park, Keun Seok Lee, Yoon Ji Choi, Soohyeon Lee, Joo Hyuk Sohn, Yeon-Hee Park, Young-Hyuck Im, Jin-Hee Ahn, Sung-Bae Kim, Jee Hyun Kim
Cancer Research and Treatment. 2016;48(4):1373-1381.   Published online 2016 March 23    DOI: https://doi.org/10.4143/crt.2015.475

Excel Download

Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study
Cancer Research and Treatment. 2016;48(4):1373-1381   Crossref logo
Link1 Link2 Link3

Phase II Study of Neoadjuvant Docetaxel/Vinorelbine Followed by Surgery and Adjuvant Doxorubicin/Cyclophosphamide in Women with Stage II/III Breast Cancer
Clinical Breast Cancer. 2006;6(6):511-517   Crossref logo
Link1 Link2

A Phase II Study of Sequential Docetaxel Followed by Doxorubicin/Cyclophosphamide as First-Line Chemotherapy For Metastatic Breast Cancer
Clinical Breast Cancer. 2003;4(4):286-291   Crossref logo
Link1 Link2

Results of Neoteam: A randomized multicenter phase II study of liposomal doxorubicin hydrochloride + trastuzumab vs conventional doxorubicin both in combination with cyclophosphamide and followed by docetaxel + trastuzumab as neoadjuvant treatment of HER2-positive primary breast cancer
Annals of Oncology. 2016;27:vi91   Crossref logo
Link1 Link2 Link3

434 Phase II Study of Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/− Trastuzumab Followed by Docetaxel in Locally Advanced Breast Cancer (LABC)
European Journal of Cancer. 2012;48:S173   Crossref logo
Link1 Link2

Doxorubicin/Pemetrexed Followed by Docetaxel Versus Doxorubicin/Cyclophosphamide Followed by Docetaxel as Neoadjuvant Treatment for Early-Stage Breast Cancer: A Randomized Phase II Trial
Clinical Breast Cancer. 2007;7(7):555-558   Crossref logo
Link1 Link2

Toxicity of Dose-Dense Docetaxel Followed by Doxorubicin with Cyclophosphamide as Adjuvant Therapy for Breast Cancer in a Phase II Study
Clinical Breast Cancer. 2007;7(9):697-704   Crossref logo
Link1 Link2

347 POSTER Ciprofloxacin, G-CSF, Pegfilgrastim, Pegfilgrastim+Ciprofloxacin as neutrophil support during neoadjuvant chemotherapy with docetaxel/doxorubicin/cyclophosphamide (TAC) in breast cancer patients
European Journal of Cancer Supplements. 2005;3(2):98   Crossref logo
Link1 Link2

A Dose-Escalating Pilot Study (NCT03017404) of Pegylated Liposomal Doxorubicin and Cyclophosphamide, Followed by Docetaxel Administration as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer
Oncology Research and Treatment. 2019;42(5):269-274   Crossref logo
Link1 Link2

Prognostic value of axillary lymph node status after neoadjuvant chemotherapy. Results from a multicentre study
Breast Diseases: A Year Book Quarterly. 2011;22(4):382-383   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.